The HLA system in hematopoietic stem cell transplantation - Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation - page 33

[12] Strong RK, Holmes MA, Li P, Braun L, Lee N, Geraghty DE. HLA-E allelic variants.
Correlating differential expression, peptide affinities, crystal structures, and thermal
stabilities. J Biol Chem 2003;278:5082-90.
[13] Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, et al. HLA-E
binds to natural killer cell receptors CD94/NKG2A. B and C. Nature 1998;391:795-9.
[14] Tomasec P, Braud VM, Rickards C, Powell MB, McSharry BP, Gadola S, et al. Surface
expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomega-
lovirus gpUL40. Science 2000;287:1031.
[15] Ulbrecht M, Modrow S, Srivastava R, Peterson PA, Weiss EH. Interaction of HLA-E with
peptides and the peptide transporter in vitro : implications for its function in antigen
presentation. J Immunol 1998;160:4375-85.
[16] Heinzel AS, Grotzke JE, Lines RA, Lewinsohn DA, McNabb AL, Streblow DN, et al.
HLA-E-dependent presentation of Mtb-derived antigen to human CD8 + T cells. J Exp
Med 2002;196:1473-81.
[17] Paul P, Cabestre FA, Ibrahim EC, Lefebvre S, Khalil-Daher I, Vazeux G, et al. Identi-
fication of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of
soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol
2000;61:1138-49.
[18] Larsen MH, Hviid TV. Human leukocyte antigen-G polymorphism in relation to expres-
sion, function, and disease. Hum Immunol 2009;70:1026-34.
[19] Chen XY, Yan WH, Lin A, Xu HH, Zhang JG, Wang XX. The 14 bp deletion polymor-
phisms in HLA-G gene play an important role in the expression of soluble HLA-G in
plasma. Tissue Antigens 2008;72:335-41.
[20] Rizzo R, Rubini M, Govoni M, Padovan M, Melchiorri L, Stignani M, et al. HLA-G 14-bp
polymorphism regulates the methotrexate response in rheumatoid arthritis. Pharma-
cogenet Genomics 2006;16:615-23.
[21] Bahram SMIC genes: from genetics to biology. Adv Immunol 2000;76:1-60.
[22] Steinle A, Li P, Morris DL, Groh V, Lanier LL, Strong RK, et al. Interactions of human
NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family.
Immunogenetics 2001;53:279-87.
[23] Bahram S, Inoko H, Shiina T, Radosavljevic M. MIC and other NKG2D ligands: from
none to too many. Curr Opin Immunol 2005;17:505-9.
[24] Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, et al. Three-
dimensional structure of the human class II histocompatibility antigen HLA-DR1.
Nature 1993;364:33-9.
[25] Charron DJ, Lotteau V, Turmel P. Hybrid HLA-DC antigens provide molecular evidence
for gene trans-complementation. Nature 1984;312:157-9.
[26] Marshall KW, Liu AF, Canales J, Perahia B, Jorgensen B, Gantzos RD, et al. Role of
the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide
ligands. J Immunol 1994;152:4946-57.
[27] Traherne JA, Horton R, Roberts AN, Miretti MM, Hurles ME, Stewart CA, et al. Genetic
analysis of completely sequenced disease-associated MHC haplotypes identifies
shuffling of segments in recent human history. PLoS Genetics 2006:2; e9.
[28] Horton R, Gibson R, Coggill P, Miretti M, Allcock RJ, Almeida J, et al. Variation analysis
and gene annotation of eight MHC haplotypes: the MHC Haplotype Project. Immuno-
genetics 2008;60:1-8.
[29] Yunis EJ, Larsen CE, Fernandez-Viña M, Awdeh ZL, Romero T, Hansen JA, et al. Inherit-
able variable sizes of DNA stretches in the human MHC: conserved extended haplo-
types and their fragments or blocks. Tissue Antigens 2003;62:1-20.
[30] Socie G, Loiseau P, Tamouza R, Janin A, Busson M, Gluckman E, et al. Both genetic and
clinical factors predict the development of graft-versus-host disease after allogeneic
hematopoietic stem cell transplantation. Transplantation 2001;72:699-706.
[31] Bettens F, Passweg J, Schanz U, Chalandon Y, Heim D, Gungor T, et al. Impact of
HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem
cell donor transplants depends on MHC-linked microsatellite polymorphisms. Biol
Blood Marrow Transpl 2012;18:608-16.
[32] Dickinson AM, Charron D. Non-HLA immunogenetics in hematopoietic stem cell
transplantation (Review). Curr Opin Immunol 2005;17:517-25.
[33] Piazza A. Haplotype and linkage disequilibrium from the three-locus phenotypes.
In: Kissmeyer-Nielsen F, editor. Histocompatibility Testing. Copenhagen, Denmark:
Munksgaard; 1975. p. 923-7.
[34] Bodmer WF. HLA: a super supergene (Review). Harvey Lectures 1978;72:91-138.
[35] Beatty PG, Boucher KM, Mori M, Milford EL. Probability of finding HLA-mismatched
related or unrelated marrow or cord blood donors. Hum Immunol 2000;61:834-40.
[36] Lonjou C, Clayton J, Cambon-Thomsen A, Raffoux C. HLA -A, -B, -DR haplotype
frequencies in France - implications for recruitment of potential bone marrow donors.
Transplantation 1995;60:375-83.

34